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Background
Pain is a complex clinical issue that influences the quality of life in all patient
populations. Although chronic and acute pain is the primary driver in the prescription
of opioids, the gold standard to measure pain, the visual analogue scale, is subjective
and can lead to inaccurate pain management. Therefore, there is a clinical need to
objectify pain. We have developed a novel device, AlgometRx Nociometer®, that
integrates a neuroselective, non-painful stimulus with measuring the subsequent
reflexive pupillary dilation response to objectively quantitate and categorize pain.
Selective stimulation of the pain-associated sensory fibers, C and Aδ, and the touch
fiber, Aβ, results in neurospecific reflex pupillary dilation. We hypothesize that this
pupillary reflex is dependent on the magnitude and type of pain (chronic vs acute) a
patient is experiencing at the time of measurement. Thus, the behavior of the sensory
fibers can be used to predict a patient-specific pain profile. In this pilot study, we
measure the nociceptive profile of patients with Complex Regional Pain Syndrome
(CRPS), a form of chronic pain, and compare to that of normal controls.
Methods
The AlgometRx Nociometer® was used to assess the neurostimulus induced pupillary
reflex dilation (nPRD). Electrodes were applied to either a finger or a toe. A one
second non-painful stimulus was applied at 5Hz, 250Hz, and 2000Hz, and the pupillary
dilation was measured for ten seconds. The area under the dilation curve (AUC) for
each frequency was compared within patients.

Results

Figure 3. Comparison of asymptomatic and symptomatic limbs in
three patients with complex regional pain syndrome using the
Neuropathy Index: (AUCAδ -AUCAβ)/AUCC.
Before & After Gabapentin Treatment

Figure 5. Nociceptive profile before and
after gabapentin in one patient with CRPS

Figure 1. Schematic depicting anatomic rational for
innocuous neuroselective stimulus evoked pupillary
dilation (nPRD).
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Figure 4. Nociceptive profile for normal
individuals

• Figure 3 shows three CRPS patients’ nPRD-derived nociceptive profiles of the
asymptomatic and symptomatic limbs. Increased sensitivity of Aβ in relation to C
and Aδ in symptomatic limbs demonstrates ability to detect differences in
nociceptive processing within an individual
• All measurements of affected limbs are higher in magnitude than unaffected
• Nociceptive index is negative in symptomatic limbs, whereas its positive in
asymptomatic limbs
• Normal control patients’ nPRD-dervied nociceptive profiles show statistically
significant difference between C and Aβ fibers
Discussion
In CRPS, the symptomatic limbs produce a negative index measure that reflects the
relative increased sensitivity of Aβ. The derangement in Aβ causes it to transmit pain
upon simple touch (allodynia). CRPS highlights the pivotal role Aβ plays in sensation
and pain modulation under different pathologic conditions. In CRPS there is a
peripheral pain driver (allodynic limb) that causes nociplastic changes centrally
depending on the severity and duration of the pathology. As seen in Figure 3, the
asymptomatic limbs are not unaffected and likely reflect nociplastic changes due
to the symptomatic limb acting as the pain driver.

Figure 2. The area under the nPRD curve (AUC) is identified in orange.

These preliminary data demonstrate the potential of the nPRD-derived Neuropathy
Index to detect, quantify and differentiate neuropathies between and within
individuals for a given condition. We plan to apply this index to patients with
vincristine induced peripheral neuropathy (VIPN). Having an objective index to
evaluate the VIPN population over their treatment duration is necessary to
characterize and quantify the unique pathophysiology of VIPN where both positive
(pain and paresthesia transmitted by C and Aδ) and negative (numbness from
diminished Aβ function) symptoms coexist.

